Michael Ho Selected Research

Michael Ho Research Topics

Disease

7	Neoplasms (Cancer) 09/2015 - 09/2003
4	Broca Aphasia (Expressive Aphasia) 01/2012 - 10/2009
3	Alzheimer Disease (Alzheimer's Disease) 07/2011 - 08/2009
3	Medulloblastoma 11/2004 - 09/2003
2	Myocardial Infarction 08/2012 - 07/2004
2	Aphasia (Dysphasia) 01/2012 - 11/2009
2	Stroke (Strokes) 01/2012 - 11/2009
2	Sarcoma (Soft Tissue Sarcoma) 07/2011 - 05/2010
2	Neuroblastoma 12/2010 - 12/2009
2	Rhabdomyosarcoma 12/2009 - 03/2009
2	Desmoplastic Small Round Cell Tumor 12/2009 - 12/2008
2	Heart Failure 03/2009 - 03/2008
1	Sepsis (Septicemia) 12/2022
1	Healthcare-Associated Pneumonia 12/2022
1	Head and Neck Neoplasms (Head and Neck Cancer) 07/2021
1	COVID-19 01/2021
1	Respiratory Insufficiency (Respiratory Failure) 01/2019
1	Critical Illness (Critically Ill) 01/2019
1	Postmenopausal Osteoporosis 01/2016
1	Osteoporosis 01/2016
1	Inflammation (Inflammations) 09/2015
1	Pathologic Constriction (Stenosis) 02/2012
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 12/2011
1	Endocardial Fibroelastosis 12/2011
1	Hypertension (High Blood Pressure) 04/2011
1	Thrombosis (Thrombus) 10/2010
1	Sleep Apnea Syndromes (Sleep Apnea) 03/2010
1	Ewing Sarcoma (Sarcoma, Ewing) 12/2009
1	Wilms Tumor (Wilm's Tumor) 12/2009
1	Rhabdoid Tumor (Rhabdoid Tumors) 12/2009
1	Clear Cell Sarcoma 12/2009
1	Renal Cell Carcinoma (Grawitz Tumor) 12/2009
1	Mesoblastic Nephroma (Congenital Mesoblastic Nephroma) 12/2009
1	Cardiac Arrhythmias (Arrythmia) 06/2008
1	Atrial Fibrillation 06/2008
1	Astrocytoma (Pilocytic Astrocytoma) 05/2008
1	Glomerulonephritis 03/2008
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2008
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2008
1	Infarction (Infarctions) 12/2006
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2005
1	Osteosarcoma (Osteogenic Sarcoma) 09/2005
1	Breast Neoplasms (Breast Cancer) 09/2005

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 07/2011 - 09/2003
3	Amyloid (Amyloid Fibrils)IBA 07/2011 - 08/2009
2	Peptides (Polypeptides)IBA 07/2011 - 08/2009
2	CopperIBA 03/2011 - 08/2009
2	Insulin-Like PeptidesIBA 05/2010 - 03/2009
2	NestinIBA 12/2009 - 03/2008
2	Phosphotransferases (Kinase)IBA 05/2008 - 09/2004
2	RNA Helicases (RNA Helicase)IBA 12/2005 - 07/2005
2	Biological ProductsIBA 11/2004 - 09/2004
1	Valproic Acid (Depakote)FDA LinkGeneric 07/2021
1	SuspensionsIBA 01/2021
1	MineralsIBA 01/2016
1	Contrast MediaIBA 09/2015
1	AutoantibodiesIBA 12/2011
1	Aligeron (AS 2)IBA 04/2011
1	Antihypertensive Agents (Antihypertensives)IBA 04/2011
1	ZincIBA 03/2011
1	PresenilinsIBA 03/2011
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 12/2010
1	Amyloid beta-PeptidesIBA 08/2009
1	LipidsIBA 08/2009
1	Hydralazine (Apresoline)FDA LinkGeneric 03/2009
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 03/2009
1	Isosorbide Dinitrate (Isordil)FDA LinkGeneric 03/2009
1	LigandsIBA 03/2009
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 03/2009
1	EpitopesIBA 12/2008
1	Ion Channels (Ion Channel)IBA 06/2008
1	Intergenic DNA (Junk DNA)IBA 06/2008
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 05/2008
1	Tyrosine Kinase InhibitorsIBA 05/2008
1	tyrosine receptor (receptor, tyrosine)IBA 05/2008
1	Warfarin (Coumadin)FDA LinkGeneric 03/2008
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 03/2008
1	Superoxide Dismutase-1IBA 01/2008
1	Retinaldehyde (Retinal)IBA 01/2008
1	RNA Splicing FactorsIBA 01/2008
1	Serine (L-Serine)FDA Link 01/2008
1	Alanine (L-Alanine)FDA Link 01/2008
1	Glial Fibrillary Acidic ProteinIBA 12/2006
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2006
1	Caspase 3 (Caspase-3)IBA 12/2006
1	Indicators and Reagents (Reagents)IBA 09/2005
1	AntibodiesIBA 09/2005
1	Stem Cell FactorIBA 09/2004
1	Tyrosine (L-Tyrosine)FDA Link 09/2004

Therapy/Procedure

6	Therapeutics 01/2016 - 09/2003
3	Transcranial Magnetic Stimulation 01/2012 - 10/2009
2	Speech Therapy (Therapy, Speech) 01/2019 - 01/2012
2	Percutaneous Coronary Intervention 08/2012 - 02/2012
1	Mechanical Ventilators (Ventilator) 12/2022
1	Length of Stay 12/2022
1	Artificial Respiration (Mechanical Ventilation) 01/2019
1	Language Therapy (Language Training) 01/2012
1	Stents 10/2010
1	Aftercare (After-Treatment) 03/2010
1	Continuous Positive Airway Pressure 03/2010